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Abstract: Isolated left ventricular non-compaction (ILVNC) is a rare congenital cardiomyo-
pathy and is associated with arrhythmias, heart failure and thromboembolism including 
ischaemic stroke. Pregnancy is a relative contraindication to thrombolysis for acute ischae-
mic stroke, although case reports suggest the treatment can be given in selected cases. We 
report a case of recurrent cryptogenic strokes in a 36-year-old female who was thrombolysed 
with good outcome at 37 weeks’ gestation and was eventually found to have ILVNC as the 
cause. She had a predilection to recurrent posterior circulatory strokes due to foetal posterior 
communicating arteries. To our knowledge this is the first case report of safe thrombolysis 
for acute ischaemic stroke in pregnancy caused by ILVNC. 
Keywords: left ventricular non-compaction, ischaemic stroke, stroke in pregnancy, foetal 
posterior communicating artery
Introduction
Stroke in the young (age <50 years) and stroke in pregnancy are both relatively rare 
but associated with significant morbidity and mortality. The underlying cause is 
usually not identified in up to 25% of cases of young-onset stroke and are classified 
as “cryptogenic stroke”; a significant proportion of cryptogenic strokes are known 
to be cardio-embolic in origin after more specialized investigations.1 Variants in the 
anatomy of the Circle of Willis, such as foetal posterior communicating arteries, 
can be risk factors for stroke in this population in the absence of cerebrovascular 
disease.2
Isolated left ventricular non-compaction syndrome (ILVNC) is a rare form of 
cardiomyopathy first described in 1990,3 and is characterised by prominent coarse 
trabeculations with deep intra-trabecular recesses in the left ventricle. These are 
postulated to be due to arrest of the final stages of myocardial compaction during 
development, giving rise to a characteristic abnormal double-layer morphology of 
thin compacted epicardium and a thick non-compacted endocardial layer. ILVNC is 
largely thought to be genetic, although recent studies showing its sudden appear-
ance and resolution in adults suggest it could also be acquired.4 ILVNC can lead to 
left-ventricular thrombus formation and thus, rarely, cardio-embolic stroke, with the 
cumulative risk of stroke in ILVNC being approximately 15% per year.5
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Stroke affects approximately 0.03% of pregnancies, and 
can be due to ischaemia, cerebral venous sinus thrombosis, or 
haemorrhage, with the highest risk in the peri- and post- 
partum periods.6 Pregnancy is a relative exclusion criterion 
for treating with intravenous recombinant tissue plasminogen 
activator (IVTPA) in hyper-acute ischaemic stroke, and deci-
sions to give IVTPA in pregnancy are made on a case-by- 
case basis.7 There is currently a paucity of evidence-based 
recommendations for diagnosis and secondary prevention of 
recurrent stroke due to ILVNC. To date there have been no 
case reports in the literature of safe IVTPA delivered in 
pregnancy for the treatment of hyper-acute ischaemic stroke 
due to ILVNC.
Materials and Methods
We describe a case with acute ischaemic stroke during 
pregnancy, on a background of recurrent strokes over the 
preceding two years, who was thrombolysed safely with 
IVTPA and was eventually found to have ILVNC as the 
only attributable cause for her strokes. She was also found 
to have foetal variants of the posterior communicating 
arteries.
Case Presentation
A 36-year-old female (gravida 2 para 1) has been known 
to our services due to bilateral cerebellar strokes 3 years 
previously, which were deemed cryptogenic after exten-
sive investigations. She had been taking clopidogrel, 
which was switched to aspirin when she became pregnant 
again. Neither she nor her family had any relevant comor-
bid disease, and she had never taken oral contraceptives, 
alcohol, illicit drugs or cigarettes. She presented with 
recurrence of right occipital and right cerebellar strokes 
[superior cerebellar artery (SCA) territory] in the second 
trimester of the current pregnancy for which, again, no 
cause was found; with no firm grounds for anti- 
coagulation, we added a prophylactic dose of low- 
molecular-weight heparin (LMWH) to the aspirin.
During both these presentations, comprehensive blood 
panels (including thyroid function, haematinics, testing for 
diabetes, thrombophilia, connective tissue and auto-immune 
screening, serum electrophoresis, fasting homocysteine, 
HIV and syphilis serology, inflammatory markers, and coa-
gulation profiles), serial Holter monitors, and transthoracic 
echocardiography (TTE), with one trans-oesophageal echo-
cardiography (TOE), were repeatedly normal. Cardiac MRI 
was not available at that time. Contrast-enhanced angiogra-
phy on magnetic resonance imaging (MRI) of the intra- and 
extra-cranial vessels showed stenosis of the distal basilar 
artery and P1 segments with bilateral foetal posterior com-
municating arteries but no features of vasculitis.
She presented again at 37 weeks’ gestation to our 
emergency department with sudden-onset right-sided 
weakness, diplopia and dysarthria at 0800h as witnessed 
by the husband, which occurred whilst they were en-route 
to work. On arrival her National Institute of Health Stroke 
Scale (NIHSS) score was 8, confirmed by the attending 
neurologist (author DSS) at 0855h. Urgent computed 
tomography (CT) scan of the head was reported normal 
at 0935h. There were no other contraindications to IVTPA 
except for her pregnancy. After urgent multidisciplinary 
discussions with her obstetrician, the cardiologist (author 
LMN), and an independent neurologist, a clinical decision 
was made to administer IVTPA which was given at 1015h, 
and she was moved to the critical care unit for neuro- 
observation.
Her diplopia and dysarthria improved initially, but 
three hours later she reported right-sided paraesthesia and 
worsening right upper limb weakness with heaviness of 
the tongue, all confirmed on examination. An urgent repeat 
CT head scan was normal, and MRI scan of the brain 
revealed a 9 mm area of restricted diffusion in the medial 
aspect of the left postero-inferior cerebellum with subtle 
hyper-intensity on the fluid-attenuated inversion recovery 
(FLAIR) sequences in keeping with a hyper-acute infarct 
in the postero-inferior cerebellar artery (PICA) territory. 
She was commenced on aspirin 300 mg, and urgent bed-
side TTE showed no left ventricular thrombus. Repeat 
MRI brain scan on day 2 showed interval development 
of 3 new foci of restricted diffusion in different territories 
of the brain, so we increased LMWH to treatment dose 
and stopped aspirin, after which she had no further clinical 
events.
She underwent an uneventful caesarean section on day 
4, and on day 5 power grade had improved to 4/5 in the 
right upper limb. However, on day 6 she redeveloped right 
sided facial tingling with worsening right limb weakness 
power 3/5, and repeat MRI revealed three new small acute 
infarcts in the cerebellum, both PICA and SCA territories 
(Figure 1); we therefore added aspirin to the anticoagula-
tion. Given the ongoing strokes despite full treatment we 
requested trans-oesophageal echocardiogram (TOE) which 
showed changes in keeping with ILVNC, further con-
firmed with cardiac MRI (Figure 2).
During the remainder of her admission, there were no 
dysrhythmias noted on critical care cardiac monitoring, 
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and serial 24-hour Holter monitors were normal. She made 
a gradual recovery with appropriate neuro-rehabilitation 
therapy, and was discharged on day 10 with minimal 
right sided weakness with the ability to walk unaided. 
We switched her treatment to warfarin with a target inter-
national normalised ratio (INR) of 2.5–3.5, and she 
returned to work 2 months later with no complications 
since. The patient has reported compliance with the war-
farin as it is more affordable in our region, with 
a therapeutic INR monitored by the cardiologist (author 
LMN). Her new infant continued to breastfeed for a total 
of one year and has grown normally with no sequelae 
noted, for which both the patient and her husband were 
grateful. The authors (DSS and LMN) have continued to 
follow up the patient to date: at almost 4 years after the 
IVTPA, anticoagulation initiation and ILVNC diagnosis, 
the child remains well and healthy as reported by the 
paediatricians.
Her younger brother, who had transiently immigrated 
to Europe during the patient’s illness, was invited for 
review by cardiology and was also found to have asymp-
tomatic ILVNC.
Discussion
Our case is a unique example of a combination of common 
stroke risk factors (pregnancy, foetal PCA remnant) with 
rare causes of cryptogenic stroke (ILVNC) conspiring to 
cause recurrent embolic strokes. The main cause of our 
patient’s recurrent strokes over the years is chiefly attribu-
table to the ILVNC, which is likely to be familial given the 
positive finding in her brother. ILVNC can be unmasked in 
hyperdynamic states such as pregnancy due to mechanical 
overloading8 and could be why the ILVNC was not picked 
up on our patient previously when she was not pregnant. 
The imaging of choice to detect ILVNC is cardiac MRI, 
which we eventually pursued in our case; this modality 
Figure 1 MRI brain images during acute admissions (grey arrows indicate area(s) of interest). 2015 admission: (A) diffusion weighted imaging (DWI) showing posterior 
circulatory artery (PCA) ischaemic strokes from 2½ years prior; (B) contrast-enhanced MRI angiography (maximum intensity projection) showing remnant foetal PCA 
cerebrovasculature. 2018 admission: (C) DWI sequences of recurrence of stroke in first trimester of current pregnancy; (D) ongoing strokes during admission post-IVTPA.
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also has the advantage of assessing myocardial fibrosis and 
offering prognostic information.9 One limitation to assert-
ing ILVNC as the main contributor to the stroke presenta-
tions in our patient is that we did not have a cardiac MRI 
scan from her index presentation a few years prior, 
although it is possible that the ILVNC may not have 
been unmasked at that time.
Risk factors for ischaemic stroke in the context of 
ILVNC include an abnormal ejection fraction, visible 
thrombus and atrial fibrillation.10 Our patient had one of 
these, and additionally was pregnant which in itself is 
a hyper-coagulable state and may have contributed to the 
formation of thrombi in the trabecular recesses. Despite 
ongoing recurrent strokes in the first few days of this 
admission, TTE did not pick up on these thrombi probably 
due to either their small size, or from a combination of 
complete embolisation, spontaneous resolution, extra- 
ventricular origin of the thrombi, or dissolution after 
IVTPA. In our patient, there was the additional risk factor 
of an abnormal foetal remnant of the posterior cerebral 
artery, which itself is known to increase the risk of stroke11 
and also explains the predilection of her cerebrovascular 
events for the posterior circulation.
We thrombolysed our patient after discussing risks and 
benefits with her, her husband, and the multi-disciplinary 
team including her obstetrician. The latest guidelines have 
recategorised pregnancy from being a contraindication to 
IVTPA to being a considered recommendation for the 
treatment when the anticipated benefits in the context of 
moderate or severe stroke outweigh the anticipated 
increased risks of uterine bleeding.12 There are case 
reports of successful IVTPA in ILVNC cases,13 but none 
during concurrent pregnancy.
Subsequent secondary prevention in ILVNC is based on 
expert opinion as no formal guidelines exist. Whilst anti- 
platelet monotherapy post-IVTPA would normally be indi-
cated, our patient’s recurrent multi-territory clinical events 
that were also shown on serial MRI brain scans despite 
standard stroke preventative therapy called for full anti- 
coagulation, even in the absence of cardiac arrhythmias 
and demonstrable left ventricular thrombus. We commenced 
LMWH and subsequently transitioned to warfarin which is 
in keeping with recommendations specific to ILVNC.14
Current guidance recommends that first-degree relatives 
of patients with ILVNC should be screened for the 
condition,10 as early diagnosis can lead to treatment such as 
prophylactic anticoagulation to prevent thromboembolic 
events in high-risk patients.14 Although not relevant to our 
patient or her sibling, we recognise that ILVNC, as is the case 
with cardiomyopathies, can be associated with underlying 
neuromuscular disorders and patients should therefore be 
clinically assessed for these too when ILVNC is detected.
Conclusion
What is Already Known About This Topic
● ILVNC is a rare but important cardio-embolic cause 
of recurrent cryptogenic strokes.
● The diagnosis requires an index of suspicion and 
a comprehensive cardiological work-up, including 
cardiac MRI as our case illustrates.
● The pathogenic role of anomalous cerebrovascula-
ture, such as foetal variants, in ischaemic stroke can 
also be unmasked during pregnancy.
What This Study Adds
● Pregnancy can exacerbate ILVNC and lead to recur-
rent cryptogenic strokes.
● IVTPA can be given safely in pregnancy without risk 
to mother or neonate in the context of embolization 
from ILVNC.
● Anticoagulation can be warranted but should be cho-
sen on a case-by-case basis based on safety and 
efficacy profiles.
Figure 2 Cardiac MRI (pseudo-4-chamber view) revealing characteristic ILVNC 
morphology in segment 4–6 with non-compacted (NC)/compacted (C) ratio of 
≥2:1.
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The clinical history and imaging data used to support the 
findings of this study are included within the article.
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